Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor

Yarden, Yosef, Schlessinger, Joseph·1987·Biochemistry

Cited by (629)

Items 201–300 of 629

  1. The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors
    Marlon Roberto Schneider, Yosef Yarden · 2015 · Oncogene
  2. Biochemical properties of the 75-kDa tumor necrosis factor receptor. Characterization of ligand binding, internalization, and receptor phosphorylation.
    Diane Pennica, Vianna T. Lam, Nancy K. Mize, R F Weber, Martyn Lewis, BRIAN M. FENDLY, Michael T. Lipari, David V. Goeddel · 1992 · Journal of Biological Chemistry
  3. Bovine papillomavirus E5 protein induces oligomerization and trans-phosphorylation of the platelet-derived growth factor β receptor
    Char‐Chang Lai, Carl Henningson, Daniel DiMaio · 1998 · Proceedings of the National Academy of Sciences
  4. The NADPH Oxidases DUOX1 and NOX2 Play Distinct Roles in Redox Regulation of Epidermal Growth Factor Receptor Signaling
    David E. Heppner, Milena Hristova, Christopher M. Dustin, Karamatullah Danyal, Aida Habibovic, Albert van der Vliet · 2016 · Journal of Biological Chemistry
  5. Characterization of two monoclonal antibodies reactive with the external domain of the platelet-derived growth factor receptor.
    Lars Rönnstrand, Louis Terracio, Lena Claesson, C H Heldin, K Rubin · 1988 · Journal of Biological Chemistry
  6. The Platelet-Activating Factor Receptor Activates the Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and Induces Proliferation of Epidermal Cells through an Epidermal Growth Factor-Receptor-Dependent Pathway
    Silvio A. Marques, Lady C. Dy, Michael D. Southall, Quiaofang Yi, Eva Smietana, Reuben Kapur, Mariangela Marques, Jeffrey Bryant Travers, Dan F. Spandau · 2002 · Journal of Pharmacology and Experimental Therapeutics
  7. Immortalizing Genes of Epstein-Barr Virus
    Tim R. Middleton, Toni A. Gahn, Jennifer M. Martin, Bill Sugden · 1991 · Advances in virus research
  8. Porcine Epidemic Diarrhea Virus-Induced Epidermal Growth Factor Receptor Activation Impairs the Antiviral Activity of Type I Interferon
    Lijun Yang, Jiayu Xu, Longjun Guo, Taijie Guo, Lu Zhang, Li Feng, Hongyan Chen, Yue Wang · 2018 · Journal of Virology
  9. Receptors for fibroblast growth factors
    JACQUELINE C COUTTS, John T. Gallagher · 1995 · Immunology and Cell Biology
  10. Structure-based virtual screening and molecular docking for the identification of potential multi-targeted inhibitors against breast cancer
    Zeeshan Yousuf, Kanzal Iman, Nouman Iftikhar, Muhammad Usman Mirza · 2017 · Breast Cancer Targets and Therapy
  11. Neu Differentiation Factor Inhibits EGF Binding
    Devarajan Karunagaran, Eldad Tzahar, Naili Liu, Duanzhi Wen, Yosef Yarden · 1995 · Journal of Biological Chemistry
  12. Insulin-dependent intermolecular subunit communication between isolated alpha beta heterodimeric insulin receptor complexes.
    L. J. Sweet, B D Morrison, Peter A. Wilden, J.E. Pessin · 1987 · Journal of Biological Chemistry
  13. In Vitro Enzymatic Characterization of Near Full Length EGFR in Activated and Inhibited States
    Chen Qiu, Mary Katherine Tarrant, Tatiana N. Boronina, Patti A. Longo, Jennifer M. Kavran, Robert Norman Cole, Philip A. Cole, Daniel J. Leahy · 2009 · Biochemistry
  14. Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma
    Yoon Soo Chang, Chang‐Min Choi, Jae Cheol Lee · 2016 · Tuberculosis & respiratory diseases
  15. Evidence supporting a passive role for the insulin receptor transmembrane domain in insulin-dependent signal transduction
    Anne L. Frattali, Judith L. Treadway, Jeffrey E. Pessin · 1991 · Journal of Biological Chemistry
  16. Crystals of the complex between human growth hormone and the extracellular domain of its receptor
    Mark H. Ultsch, Abraham M. de Vos, Anthony A. Kossiakoff · 1991 · Journal of Molecular Biology
  17. Spatio-temporal modeling of signaling protein recruitment to EGFR
    Ming-yu Hsieh, Shujie Yang, Mary Ann Raymond‐Stintz, Jeremy S. Edwards, Bridget Smith Wilson · 2010 · BMC Systems Biology
  18. Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
    Adhemar Longatto‐Filho, Celine Marques Pinheiro, Olga Martinho, Marise AR Moreira, Luiz Fernando Jubé, Geraldo Silva Queiroz, Fernando Carlos Schmitt, Fátima Baltazar, Rui Manuel Reis · 2009 · BMC Cancer
  19. The Extracellular Domain of the Epidermal Growth Factor Receptor
    Pamela M. Brown, Maria Teresa Debanne, Suzanne Grothé, Derk J. Bergsma, Mireille Caron, Cyril M. Kay, Maureen D. O'Connor‐McCourt · 1994 · European Journal of Biochemistry
  20. Dimerization Mediated through a Leucine Zipper Activates the Oncogenic Potential of the met Receptor Tyrosine Kinase
    Gerard A. Rodrigues, Morag Park · 1993 · Molecular and Cellular Biology
  21. Epidermal growth factor receptor function in early mammalian development
    Lynn M. Wiley, Eileen D. Adamson, Eleanor C. Tsark · 1995 · BioEssays
  22. Visualization of Epidermal Growth Factor (EGF) Receptor Aggregation in Plasma Membranes by Fluorescence Resonance Energy Transfer
    Kermit L. Carraway, John G. Koland, Richard A. Cerione · 1989 · Journal of Biological Chemistry
  23. Comparing the Epidermal Growth Factor Interaction with Four Different Cell Lines: Intriguing Effects Imply Strong Dependency of Cellular Context
    Hanna Björkelund, Lars Gedda, Karl Andersson · 2011 · PLoS ONE
  24. Direct visualization and quantitative analysis of epidermal growth factor‐induced receptor clustering
    Nico van Belzen, Philip J. Rijken, Willem J. Hage, Siegfried W. de Laat, Arie J. Verkleij, Johannes Boonstra · 1988 · Journal of Cellular Physiology
  25. Epidermal Growth Factor and Related Growth Factors
    Ruth Ann Yates, Lillian B. Nanney, Ronald E. Gates, Lloyd E. King · 1991 · International Journal of Dermatology
  26. Aggregation-induced activation of the epidermal growth factor receptor protein tyrosine kinase
    Moosa Mohammadi, Annemarie Honegger, Andrey Sorokin, Axel Ullrich, Joseph Schlessinger, David R. Hurwitz · 1993 · Biochemistry
  27. High‐yield trapping of EGF‐induced receptor dimers by chemical cross‐linking 1
    Bradford O. Fanger, Judy E. Stephens, James V. Staros · 1989 · The FASEB Journal
  28. The Scientific Basis of Early Detection of Epithelial Ovarian Cancer: The National Ovarian Cancer Early Detection Program (Nocedp)
    David A. Fishman, Kenny Bozorgi · 2002 · Springer eBooks
  29. Cellular distribution and biological activity of epidermal growth factor receptors in A431 cells are influenced by cell‐cell contact
    Rosemarie B. Lichtner, Volker Schirrmacher · 1990 · Journal of Cellular Physiology
  30. Noncontiguous regions in the extracellular domain of EGF receptor define ligand-binding specificity.
    Irit Lax, R Fischer, C Ng, Julia A. Segre, Axel Ullrich, David Givol, Joseph Schlessinger · 1991 · Cell Regulation
  31. Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor
    Morten Pedersen Oksvold, Christine B.F. Thien, Jannicke Widerberg, Andrew Chantry, Henrik Sverre Huitfeldt, Wallace Y. Langdon · 2003 · Oncogene
  32. Peptide Vaccines of the HER-2/neu Dimerization Loop Are Effective in Inhibiting Mammary Tumor Growth In Vivo
    Stephanie D. Allen, Joan T. Garrett, Sharad V. Rawale, Audra L. Jones, Gary S. Phillips, Guido Forni, John C Morris, Robert G. Oshima, Pravin T. P. Kaumaya · 2007 · The Journal of Immunology
  33. A 40-kDa epidermal growth factor/transforming growth factor alpha-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor.
    Daisuke Kohda, M. Odaka, Irit Lax, Hiroshi Kawasaki, Koichi Suzuki, Axel Ullrich, Joseph Schlessinger, Fuyuhiko Inagaki · 1993 · Journal of Biological Chemistry
  34. Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells
    Michal Firon, Miriam Shaharabany, Rom T. Altstock, Judith Horev, ARMAND ABRAMOVICI, James H. Resau, George F. Vande Woude, Ilan Tsarfaty · 2000 · Oncogene
  35. Fertilization in the Mouse
    Bayard T. Storey, Gregory S. Kopf · 1991 · Springer eBooks
  36. A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses.
    Sima Lev, Yosef Yarden, David Givol · 1992 · Journal of Biological Chemistry
  37. An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.
    Rachel Ben-Levy, Elior Peles, Rina Goldman-Michael, Yosef Yarden · 1992 · Journal of Biological Chemistry
  38. Induction of tumor suppression and glandular differentiation of A549 lung carcinoma cells by dominant-negative IGF-I receptor
    Yixing Jiang, William N. Rom, Ting-An Yie, C X, Kam-Meng Tchou-Wong · 1999 · Oncogene
  39. Inhibition of colony-stimulating factor-1 activity by monoclonal antibodies to the human CSF-1 receptor
    Charles J. Sherr, RA Ashmun, James R. Downing, Masahiro Ohtsuka, SG Quan, David W. Golde, Martine F. Roussel · 1989 · Blood
  40. Ectopic expression of a c-kitW42 minigene in transgenic mice: recapitulation of W phenotypes and evidence for c-kit function in melanoblast progenitors.
    Prabir Ray, Kay M. Higgins, Jimmy C. Tan, Tang‐Yuan Chu, Nelson S. Yee, H Nguyen, Elizabeth Lacy, Peter Besmer · 1991 · Genes & Development
  41. Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment
    Soma Ghosh, Ilaria Marrocco, Yosef Yarden · 2020 · Advances in cancer research
  42. ERBB2 kinase domain mutation in the lung squamous cell carcinoma
    Jong Woo Lee, Young Hwa Soung, Su Young Kim, Suk Woo Nam, Won Sang Park, Young Pil Wang, Keon Hyun Jo, Seok Whan Moon, Sang Yong Song, Jung Young Lee et al. · 2005 · Cancer Letters
  43. Substitution of the insulin receptor transmembrane domain with the c-neu/erbB2 transmembrane domain constitutively activates the insulin receptor kinase in vitro.
    Kazunori D. Yamada, Edison Gonçalves, C. Ronald Kahn, Steven E. Shoelson · 1992 · Journal of Biological Chemistry
  44. Single-Molecule Imaging of Signaling Molecules in Living Cells
    Yasushi Sako, Kayo Hibino, Takayuki Miyauchi, Yoshikazu Miyamoto, Masahiro Ueda, Toshio Yanagida · 2000 · Single Molecules
  45. Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibody
    Hironobu Sunada, Peter Yu, Jeffrey S. Peacock, John M. Mendelsohn · 1990 · Journal of Cellular Physiology
  46. Identification and assay of fibroblast growth factor receptors
    Mikio Kan, Ergang Shi, Wallace L. McKeehan · 1991 · Methods in enzymology on CD-ROM/Methods in enzymology
  47. A Proximity Ligation Assay Using Transiently Transfected, Epitope-Tagged Proteins: Application for in Situ Detection of Dimerized Receptor Tyrosine Kinases
    Aaron S. Gajadhar, Abhijit Guha · 2010 · BioTechniques
  48. Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor.
    Rachel Levy-Toledano, L. Heleen P., Domenico Accili, Simeon I. Taylor · 1994 · The EMBO Journal
  49. Quaternary structure of the Mr 46,000 mannose 6-phosphate specific receptor: effect of ligand, pH and receptor concentration on the equilibrium between dimeric and tetrameric receptor forms
    Abdül Waheed, Annette Hille‐Rehfeld, Ulrich Junghans, Kurt VON FIGURA · 1990 · Biochemistry
  50. Characterization of the epidermal growth factor receptor associated with cytoskeletons of A431 cells
    Linda M. Roy, Cynthia K. Gittinger, Gary E. Landreth · 1989 · Journal of Cellular Physiology
  51. The free energy landscape in translational science: how can somatic mutations result in constitutive oncogenic activation?
    Chung‐Jung Tsai, Ruth Nussinov · 2014 · Physical Chemistry Chemical Physics
  52. The association between anti-tumor potency and structure-activity of protein-kinases inhibitors based on quinazoline molecular skeleton
    Yang Li, Jie Xiao, Qizhi Zhang, Wen‐Mei Yu, Mengqin Liu, Yu C. Guo, Jun He, Yunmei Liu · 2018 · Bioorganic & Medicinal Chemistry
  53. Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1.
    Bentley Cheatham, Steven E. Shoelson, Kazunori D. Yamada, Edison Gonçalves, C. Ronald Kahn · 1993 · Proceedings of the National Academy of Sciences
  54. Insulin-dependent covalent reassociation of isolated alpha beta heterodimeric insulin receptors into an alpha 2 beta 2 heterotetrameric disulfide-linked complex.
    B D Morrison, M L Swanson, Laurel J. Sweet, Jeffrey E. Pessin · 1988 · Journal of Biological Chemistry
  55. Renal toxicity of anticancer agents targeting HER2 and EGFR
    Laura Cosmai, Maurizio Alberto Gallieni, Camillo Porta · 2015 · Journal of Nephrology
  56. EGFR forms ligand-independent oligomers that are distinct from the active state
    Patrick O. Byrne, Kalina A. Hristova, Daniel J. Leahy · 2020 · Journal of Biological Chemistry
  57. Peptide Aptamers with Binding Specificity for the Intracellular Domain of the ErbB2 Receptor Interfere with AKT Signaling and Sensitize Breast Cancer Cells to Taxol
    Christian Kunz, Corina Borghouts, Claudia Buerger, Bernd Groner · 2006 · Molecular Cancer Research
  58. Design, synthesis, and molecular docking studies of novel pomalidomide-based PROTACs as potential anti-cancer agents targeting EGFR WT and EGFR T790M
    Moustafa O. Aboelez, Amany Belal, Guangya Xiang, Xiang Ma · 2022 · Journal of Enzyme Inhibition and Medicinal Chemistry
  59. Insulin and epidermal growth factor receptor family members share parallel activation mechanisms
    Kathryn M. Ferguson, Chun Hu, Mark A. Lemmon · 2020 · Protein Science
  60. Chapter 7 Effects of Gravity on the Cellular Response to Epidermal Growth Factor
    Philip J. Rijken, Johannes Boonstra, Arie J. Verkleij, Siegfried W. de Laat · 1994 · Advances in space biology and medicine
  61. Ligand-Induced Phosphorylation of the Colony-Stimulating Factor 1 Receptor Can Occur through an Intermolecular Reaction That Triggers Receptor Down Modulation
    Masahiro Ohtsuka, Martine F. Roussel, Charles J. Sherr, James R. Downing · 1990 · Molecular and Cellular Biology
  62. 1 Developmental Activities of the Epidermal Growth Factor Receptor
    Eileen D. Adamson · 1990 · Current topics in developmental biology/Current Topics in Developmental Biology
  63. Magnetogenetics as a promising tool for controlling cellular signaling pathways
    Anastasiia Latypova, Alexey V. Yaremenko, Надежда Александровна Печникова, Артем С. Минин, Ilya V. Zubarev · 2024 · Journal of Nanobiotechnology
  64. Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism Spectrum Disorders (ASDs)
    Anthony J. Russo · 2014 · Journal of Central Nervous System Disease
  65. Effect of Tyrosine Mutations on the Kinase Activity and Transforming Potential of an Oncogenic Human Insulin-like Growth Factor I Receptor
    Yixing Jiang, Joseph L.‐K. Chan, Cong S. Zong, Lu‐Hai Wang · 1996 · Journal of Biological Chemistry
  66. Receptor-Targeted Cancer Therapy
    Mark Richter, Hongtao Zhang · 2005 · DNA and Cell Biology
  67. Structure-function relationships in human epidermal growth factor studied by site-directed mutagenesis and proton NMR
    Ulrich Hommel, Timothy J. Dudgeon, Anthony Fallon, R. Mark Edwards, Iain Donald Campbell · 1991 · Biochemistry
  68. Characterization of Interferon-α Binding Sites on Human Cell Lines
    Catherine Vanden Broecke, Lawrence M. Pfeffer · 1988 · Journal of Interferon Research
  69. Receptor-receptor interactions in heteroreceptor complexes: a new principle in biology. Focus on their role in learning and memory
    Kjell Fuxé, Dasiel O Borroto-Escuela, Francisco Ciruela, Diego Guidolin, Luigi F. Agnati · 2014 · Neuroscience Discovery
  70. Molecular weights of glycosylated and nonglycosylated forms of recombinant human stem cell factor determined by low-angle laser light scattering
    Tsutomu Arakawa, Keith E. Langley, Keiichi Kameyama, Toshio Takagi · 1992 · Analytical Biochemistry
  71. Intermolecular disulfide bonds are not required for the expression of the dimeric state and functional activity of the transferrin receptor.
    E. Alvarez, Núria Gironès, Roger J. Davis · 1989 · The EMBO Journal
  72. Urodilatin and β-ANF: Binding properties and activation of particulate guanylate cyclase
    Jörg-Martin Heim, Stefan Kiefersauer, Hans‐Jürgen Fülle, R. Gerzer · 1989 · Biochemical and Biophysical Research Communications
  73. Direct identification of residues of the epidermal growth factor receptor in close proximity to the amino terminus of bound epidermal growth factor.
    Randall L. Woltjer, T. J. Lukas, James V. Staros · 1992 · Proceedings of the National Academy of Sciences
  74. Role of Epidermal Growth Factor Receptor Signaling in the Interaction of Neisseria meningitidis with Endothelial Cells
    Heiko Slanina, Sabrina Mündlein, Sabrina Hebling, Alexandra Schubert‐Unkmeir · 2013 · Infection and Immunity
  75. SGLT1 is required for the survival of triple‐negative breast cancer cells via potentiation of EGFR activity
    Huiquan Liu, Ayse Ertay, Ping Peng, Juanjuan Li, Dian Liu, Hua Xiong, Yanmei Zou, Hong Qiu, David C. Hancock, Xianglin Yuan et al. · 2019 · Molecular Oncology
  76. Modulating effects of the extracellular sequence of the human insulinlike growth factor I receptor on its transforming and tumorigenic potential
    Dongxu Liu, William J. Rutter, L H Wang · 1993 · Journal of Virology
  77. Luciferase Fragment Complementation Imaging of Conformational Changes in the Epidermal Growth Factor Receptor
    Katherine S. Yang, Ma. Xenia G. Ilagan, David R Piwnica-Worms, LINDA JOY PIKE · 2009 · Journal of Biological Chemistry
  78. Targeting the Dimerization of Epidermal Growth Factor Receptors with Small‐Molecule Inhibitors
    Robert Yang, Katherine S. Yang, LINDA JOY PIKE, Garland R. Marshall · 2010 · Chemical Biology & Drug Design
  79. Arachidonate-Induced Tyrosine Phosphorylation of Epidermal Growth Factor Receptor and Shc-Grb2-Sos Association
    Nickolai O. Dulin, Andrey Sorokin, Janice G. Douglas · 1998 · Hypertension
  80. Ligand-induced Desensitization of 125I-Epidermal Growth Factor Internalization
    Dhandapani Kuppuswamy, LINDA JOY PIKE · 1989 · Journal of Biological Chemistry
  81. Overexpression of epidermal growth factor receptor in NIH-3T3-transfected cells slows its lateral diffusion and rate of endocytosis.
    Morris Benveniste, Etta Livneh, Joseph Schlessinger, Zvi Kam · 1988 · The Journal of Cell Biology
  82. Receptor protein tyrosine kinases
    Deborah L. Cadena, Gordon N. Gill · 1996
  83. BCAP31 drives TNBC development by modulating ligand-independent EGFR trafficking and spontaneous EGFR phosphorylation
    Wenyan Fu, Hefen Sun, Yang Zhao, Mengting Chen, Xueli Yang, Yang Liu, Wei Jin · 2019 · Theranostics
  84. Role of EGF Receptor Regulatory Networks in the Host Response to Viral Infections
    Cathleen R. Carlin · 2022 · Frontiers in Cellular and Infection Microbiology
  85. Loss of CDH1 up‐regulates epidermal growth factor receptor via phosphorylation of YBX1 in non‐small cell lung cancer cells
    Xianfang Liu, Ling Su, Xiangguo Liu · 2013 · FEBS Letters
  86. Lapatinib Inhibits Breast Cancer Cell Proliferation by Influencing PKM2 Expression
    Mingxiu Guan, Yingna Tong, Minghua Guan, Xiaobin Liu, Meng Wang, Ruifang Niu, Fei Zhang, Dong Dong, Jie Shao, Yunli Zhou · 2018 · Technology in Cancer Research & Treatment
  87. Protein Kinase C Inhibition of the Epidermal Growth Factor Receptor Tyrosine Protein Kinase Activity is Independent of the Oligomeric State of the Receptor
    Ingrid C. Northwood, Roger J. Davis · 1989 · Journal of Biological Chemistry
  88. Discrimination of driver and passenger mutations in epidermal growth factor receptor in cancer
    P. Anoosha, Liang‐Tsung Huang, Ramasamy Sakthivel, Devarajan Karunagaran, M. Michael Gromiha · 2015 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  89. Pathophysiology of glial growth factor receptors
    Gennadij Raivich, Georg W. Kreutzberg · 1994 · Glia
  90. Analogs of human epidermal growth factor which partially inhibit the growth factor‐dependent protein‐tyrosine kinase activity of the epidermal growth factor receptor
    Risë K. Matsunami, Stephen R. Campion, Salil K. Niyogi, Audrey Stevens · 1990 · FEBS Letters
  91. Relationship between insulin receptor subunit association and protein kinase activation: insulin-dependent covalent and manganese/magnesium ATP dependent noncovalent association of .alpha..beta. heterodimeric insulin receptors into an .alpha.2.beta.2 heterotetrameric state
    Peter A. Wilden, Brian D. Morrison, Jeffrey E. Pessin · 1989 · Biochemistry
  92. Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathways
    Weishan Liang, Yongjiang Zheng, Ji Zhang, Xiaoqiang Sun · 2019 · BMC Bioinformatics
  93. Identification of specific gravity sensitive signal transduction pathways in human A431 carcinoma cells
    Philip J. Rijken, Rolf P. de Groot, Wiebe Kruijer, Siegfried W. de Laat, Arie J. Verkleij, Johannes Boonstra · 1992 · Advances in Space Research
  94. Morphogenetic Effects of Neuregulin (Neu Differentiation Factor) in Cultured Epithelial Cells
    Alexander Chausovsky, Ilan Tsarfaty, Zvi Kam, Yosef Yarden, Benjamin Geiger, Alexander D. Bershadsky · 1998 · Molecular Biology of the Cell
  95. Cryo-electron Microscopic Analysis of Single-Pass Transmembrane Receptors
    Kai Cai, Xuewu Zhang, Xiao‐chen Bai · 2022 · Chemical Reviews
  96. EGF receptor modulates HEV entry in human hepatocytes
    Jil Alexandra Schrader, Thomas L. Burkard, Yannick Brüggemann, André Gömer, Toni Luise Meister, Rebecca Fu, Ann-Kathrin Mehnert, Viet Loan Dao Thi, Patrick Behrendt, David Durantel et al. · 2023 · Hepatology
  97. Targeting HER2 Positive Breast Cancer with Chemopreventive Agents
    J. Wahler, Nanjoo Suh · 2015 · Current Pharmacology Reports
  98. Down‐regulation of IGF‐IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice
    Aiqiang Dong, Minjian Kong, Zhiyuan Ma, Jianfang Qian, Xiao‐Hong Nancy Xu · 2006 · Cell Biology International
  99. The Epidermal Growth Factor Receptor Forms Location-Dependent Complexes in Resting Cells
    Sibel Yavas, Radek Macháň, Thorsten Wohland · 2016 · Biophysical Journal
  100. A Brief History of Single-Particle Tracking of the Epidermal Growth Factor Receptor
    David T. Clarke, Marisa L. Martin-Fernandez · 2019 · Methods and Protocols